Alerus Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$10.2M Sell
94,051
-2,525
-3% -$261K 1.77% 11
2015
Q4
$9.92M Buy
96,576
+870
+0.9% +$87.5K 1.66% 10
2015
Q3
$8.93M Buy
95,706
+7,720
+9% +$747K 1.58% 11
2015
Q2
$8.85M Buy
87,986
+80
+0.1% +$8.01K 1.47% 11
2015
Q1
$8.83M Buy
87,906
+12,376
+16% +$1.26M 1.47% 11
2014
Q4
$7.9M Buy
75,530
+2,575
+4% +$271K 1.34% 12
2014
Q3
$7.78M Sell
72,955
-13,896
-16% -$1.44M 1.35% 11
2014
Q2
$9.09M Buy
86,851
+49,113
+130% +$4.96M 1.57% 9
2014
Q1
$8.62M Sell
37,738
-24,286
-39% -$2.25M 1.86% 7
2013
Q4
$5.68M Sell
62,024
-24,036
-28% -$2.22M 1.25% 23
2013
Q3
$7.46M Sell
86,060
-7,203
-8% -$646K 1.49% 13
2013
Q2
$8.03M Buy
+93,263
New +$7.91M 1.24% 22

Other funds holding JNJ

Alerus Investment Advisors's JNJ Position: Q1 2016 in Review

Alerus Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 2.6% in Q1 2016, selling an estimated $261K and leaving 94,051 shares worth $10.2M. The position accounts for 1.77% of the portfolio, ranked #11.

Alerus Investment Advisors first reported a position in JNJ in Q2 2013 and has held it in 12 quarters since. 2,204 funds tracked by Wall St. Rank hold JNJ as of Q1 2016.

  • Alerus Investment Advisors held 94,051 shares of Johnson & Johnson worth $10.2M as of Q1 2016.
  • Alerus Investment Advisors sold 2,525 Johnson & Johnson shares in Q1 2016, an estimated $261K.
  • Johnson & Johnson made up 1.77% of Alerus Investment Advisors's portfolio in Q1 2016, its #11 holding.
  • Alerus Investment Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 12 quarters since.
  • 2,204 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.